These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4070209)

  • 21. [Medical and social aspects of tuberculosis prevention in multi-million urban areas].
    Grishko AN
    Probl Tuberk; 1994; (3):13-6. PubMed ID: 7937661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isoniazid preventive therapy in human immunodeficiency virus-infected persons. Long-term effect on development of tuberculosis and survival.
    Moreno S; Miralles P; Diaz MD; Baraia J; Padilla B; Berenguer J; Alberdi JC
    Arch Intern Med; 1997 Aug 11-25; 157(15):1729-34. PubMed ID: 9250234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Frequency and clinical characteristics of the reactivation of pulmonary tuberculosis after drug therapy].
    Oĭfebakh MI; Rudoĭ NM; Asambaev AA
    Probl Tuberk; 1972; 50(5):31-4. PubMed ID: 5029676
    [No Abstract]   [Full Text] [Related]  

  • 24. Risk factors for development of tuberculosis after isoniazid chemoprophylaxis in human immunodeficiency virus-infected patients.
    Casado JL; Moreno S; Fortún J; Antela A; Quereda C; Navas E; Moreno A; Dronda F
    Clin Infect Dis; 2002 Feb; 34(3):386-9. PubMed ID: 11753825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How much isoniazid is needed for prevention of tuberculosis among immunocompetent adults?
    Moulding T
    Int J Tuberc Lung Dis; 2000 May; 4(5):485-6. PubMed ID: 10815744
    [No Abstract]   [Full Text] [Related]  

  • 26. [Prevention of tuberculosis in patients in psychiatric hospitals].
    Fisher IuIa; Sheĭnman VL; Gutorova VA
    Probl Tuberk; 1991; (1):18-22. PubMed ID: 2034610
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The effect of anti-recurrence treatment with isoniazid in combination with etimizol on the immune reactivity of Group III ambulatory care patients].
    Savvateeva VG; Maslauskene TP; Makarova VM; Lokhov MG
    Probl Tuberk; 1990; (8):3-5. PubMed ID: 2147770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [An optimal method of pharmacological prevention of tuberculosis among adolescents].
    Ganiev KG; Butyl'chenko OV
    Probl Tuberk; 1992; (5-6):6-9. PubMed ID: 1409524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exposure to open tuberculosis on a neonatal unit.
    Isaacs D; Jones CA; Dalton D; Cripps T; Vidler L; Rochefort M; Bide E; Banner P; Crawford H
    J Paediatr Child Health; 2006 Sep; 42(9):557-9. PubMed ID: 16925546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Evaluation of compliance with antituberculous chemoprophylaxis among recluse population of the Jaen penitentiary center].
    Romero Saldaña M; Vaquero Abellán M; Gallego Rubio R; Aguilera López MD; de Celis Cornejo JM; Barquín García E; Zurita Serrano R
    Rev Esp Salud Publica; 1997; 71(4):391-9. PubMed ID: 9490193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Ways of increasing chemotherapy effectiveness in pulmonary tuberculosis].
    Ershov AI; Tikhonov VA; Grigaliunas AP; Sushkin AG; Guzeeva SA
    Vrach Delo; 1981 May; (5):21-5. PubMed ID: 7257254
    [No Abstract]   [Full Text] [Related]  

  • 32. [Compliance, tolerance and effectiveness of a short chemoprophylaxis regimen for the treatment of tuberculosis].
    Martínez Alfaro E; Solera J; Serna E; Cuenca D; Castillejos ML; Espinosa A; Sáez L
    Med Clin (Barc); 1998 Oct; 111(11):401-4. PubMed ID: 9834911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 2. Results of rifampicin treatment for advanced pulmonary tuberculosis patients resistant to conventional antituberculous drugs].
    Kekkaku; 1971 Nov; 46(11):423-8. PubMed ID: 4335256
    [No Abstract]   [Full Text] [Related]  

  • 34. [Pulmonary tuberculosis. 2. Therapy].
    Bölcskei P
    Fortschr Med; 1983 Jun; 101(23):1075-80, 1090. PubMed ID: 6411560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Proceedings: Results of a controlled trial of intermittent ambulatory therapy of infectious pulmonary tuberculosis with comparison of various maintenance regimens].
    Ganguin HG; Cramer G; Götz J; Holzhauer H; Niegsch G; Sieler H; Velten G; Völker L
    Z Erkr Atmungsorgane Folia Bronchol; 1973; 138(1):107-15. PubMed ID: 4203235
    [No Abstract]   [Full Text] [Related]  

  • 36. Relapse in persons treated for drug-susceptible tuberculosis in a population with high coinfection with human immunodeficiency virus in New York City.
    Driver CR; Munsiff SS; Li J; Kundamal N; Osahan SS
    Clin Infect Dis; 2001 Nov; 33(10):1762-9. PubMed ID: 11595988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between HIV and tuberculosis: technical guide.
    Bull Pan Am Health Organ; 1993; 27(3):297-310. PubMed ID: 8220525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The reactivation of pulmonary tuberculosis in persons in registry groups III and VII and those removed from dispensary observation].
    Voloshina EP
    Probl Tuberk; 1989; (12):53-5. PubMed ID: 2628978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia.
    Toungoussova S; Caugant DA; Sandven P; Mariandyshev AO; Bjune G
    Int J Tuberc Lung Dis; 2002 May; 6(5):406-14. PubMed ID: 12019916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The use of fenazid in patients with pulmonary tuberculosis with poor isoniazid tolerance].
    Borisova MI; Stakhanov VA; Sharkova TI; Ivashchenko NA
    Probl Tuberk Bolezn Legk; 2003; (7):34-7. PubMed ID: 12939876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.